News | June 16, 2011

Advances in Molecular Imaging Research and Technology Take Center Stage at SNM 2011

June 16, 2011 — More than 5,500 physicians, technologists, physicists, scientists and exhibitors gathered last week at the Society of Nuclear Medicine's (SNM) 2011 annual meeting, held June 4-8 in San Antonio, Texas. In addition to the more than 70 continuing education sessions, 1,818 scientific papers and posters were presented at the meeting and 165 companies were represented on the exhibit hall floor.

The annual meeting opened with the SNM plenary session on Sunday, June 5, as Bruce R. Rosen, M.D., Ph.D., professor of radiology at Harvard Medical School, delivered the Henry N. Wagner Jr. Lectureship. His presentation, "PET and MRI: A Match Made in Heaven or the Odd Couple?" examined both the potential and pitfalls of combined studies using positron emission tomography (PET) and magnetic resonance imaging (MRI).

In addition, two esteemed SNM awards were presented at the opening plenary session. Sanjiv "Sam" Gambhir, M.D., Ph.D., professor of radiology and chairman-designate at Stanford University School of Medicine, received the Georg Charles de Hevesy Nuclear Pioneer Award for his contributions to the nuclear medicine profession. Markus Schwaiger, M.D., director of nuclear medicine at Klinikum Rechts der Isar of Technical University of Munich in Germany, received the Paul C. Aebersold Award for outstanding achievement in basic science applied to nuclear medicine.

Monday's special plenary session welcomed in a new leadership team for SNM as George Segall, M.D., took the helm as the society's 2011-2012 president. Frederic H. Fahey, DSc, and Gary Dillehay, M.D., assumed their roles as president-elect and vice president-elect, respectively. Also at this session, the Hal Anger Lectureship, entitled "Progress in Time-of-Flight PET by Fits and Starts," was presented by Joel S. Karp, Ph.D., professor of radiology at the University of Pennsylvania.

The 2011 annual meeting concluded on Wednesday, June 8, with an overview of the research presented throughout the sessions. Groundbreaking advances were demonstrated in many areas, including cardiology, oncology, neurology and general nuclear medicine. The 2011 Image of the Year, which illustrates the ability of positron emission tomography (PET)/computed tomography (CT) scans to identify abnormal bone reaction in patients who have received spinal fixation hardware implants, was also presented at this session.

For the first time, SNM has developed a virtual meeting for those unable to attend certain sessions or make the trip to San Antonio. The virtual meeting captured 70 sessions — including 35 continuing education sessions, 20 technologist sessions and 15 scientific sessions — which are now available at www.snm.org/virtualmeeting. The 2012 SNM annual meeting will take place June 9-13 in Miami, Fla.

For more information: www.snm.org.

Related Content

DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
News | Peripheral Artery Disease (PAD)| September 13, 2017
A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results of PQ Bypass’ Detour...
News | Cardiac Diagnostics| September 12, 2017
Contracting shingles, a reactivation of the chickenpox virus, increases a person’s risk of stroke and heart attack,...
Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics| September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, accordin
Overlay Init